<DOC>
	<DOCNO>NCT02397499</DOCNO>
	<brief_summary>This multi-center , randomize , double-blinded , placebo-controlled study evaluate safety efficacy LIPO-202 reduction central abdominal bulging due subcutaneous fat non-obese subject .</brief_summary>
	<brief_title>Evaluating Safety Efficacy LIPO-202 Reduction Central Abdominal Bulging Due Subcutaneous Fat</brief_title>
	<detailed_description />
	<criteria>Healthy male nonpregnant female subject Capable provide write consent . BMI &lt; 30 kg/m2 Stable diet exercise routine Central abdominal bulging evaluate clinician least slight bulge , flat Have treatment fat around abdomen , include surgical procedure ( tummy tuck , liposuction ) , injection fat loss treatment device reduce fat abdomen . Plan start weight loss exercise program study . Known hypersensitivity study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>